Predictive testing for DPD deficiency in a patient with familial history of fluoropyrimidine-associated toxicity

Personalized Medicine
Felicia Stefania FalvellaFilippo Pietrantonio

Abstract

Reduced activity of DPD leads to severe toxicity in cancer patients receiving standard doses of fluoropyrimidines, particularly in the case of combination regimens. We describe a 38-year-old man with a resectable metastasis from hereditary nonpolyposis colorectal cancer, with indication of neoadjuvant chemotherapy and a family history of fluoropyrimidine-associated toxicity. We tested our patient for functional DPYD variants, before any choice of the neoadjuvant regimen, including for the c.496A>G, already described in his mother, and a deep intronic variant c.1129-5923C>G recently reported associated to severe toxicity. Our patient was found to be heterozygous for both c.469A>G and c.1129-5923C>G DPYD variants. We thus offered the most active perioperative regimen, capecitabine, oxaliplatin, irinotecan plus bevacizumab by which we reduced the dosing of capecitabine to 50%. Treatment was well tolerated, with grade 2 diarrhea as the most significant adverse event, and led to a complete pathological response after liver resection. We provide a rationale approach to improve the safety of fluoropirimidine-based therapy in a patient with family history of fluoropyrimidine-associated toxicity.

References

Aug 31, 2007·Journal of the National Cancer Institute·Janelle M HoskinsHoward L McLeod
Sep 8, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E BajettaS Pusceddu
Apr 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·René AdamDenis Castaing
Jan 21, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B NordlingerUNKNOWN Sixth International Colorectal Liver Metastases Workshop
Apr 19, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maarten J DeenenAnnemieke Cats
Sep 17, 2011·Pharmacogenomics·Ursula AmstutzCarlo R Largiadèr
Sep 1, 2012·Clinica Chimica Acta; International Journal of Clinical Chemistry·Johanna SistonenCarlo R Largiadèr
May 9, 2013·Pharmacogenomics·André Bp van Kuilenburg, Jan Gerard Maring

❮ Previous
Next ❯

Citations

Mar 19, 2015·British Journal of Clinical Pharmacology·Felicia Stefania FalvellaFilippo Pietrantonio
Apr 24, 2015·International Journal of Molecular Sciences·Felicia Stefania FalvellaFilippo Pietrantonio

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.